Publications, posters & presentations

Publications, posters & presentations -
our significant research

Filter
Research Area
Technology
Resource type
Category
101 results found
Aug 10, 2022
Publication
Novavax led
The Lancet Infectious Diseases
COVID-19
Safety and immunogenicity following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): a secondary analysis of a randomised, placebo-controlled, phase 2 trial
Mallory, Raburn M., Formica, Neil, Pfeiffer, Susan, et al.
Jun 2, 2022
Publication
Novavax included/third party
Malaria Journal
Malaria, Matrix-M™ adjuvant
Evaluation of the Pfs25-IMX313/Matrix-M malaria transmission-blocking candidate vaccine in endemic settings
Mulamba, Charles, Williams, Chris, Kreppel, Katharina, et al.
May 1, 2022
Publication
Collaborative
The Lancet HIV
COVID-19
Immunogenicity and safety of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine in people living with and without human immunodeficiency virus type 1 infection
Madhi, Shabir A., Moodley, Dhayendre, Hanley, Sherika, et al.
Apr 8, 2022
Publication
Collaborative
Pre-print
COVID-19
NVX-CoV2373 vaccination induces functional SARS-CoV-2–specific CD4+ and CD8+ T cell responses
Moderbacher, Carolyn Rydyznski, Kim, Christina, Mateus, Jose, et al.
Apr 1, 2022
Clinical trial protocol
COVID-19
Current Protocol for Phase 3 Clinical Trial of NVX-CoV2373 in the U.S. and Mexico
Feb 21, 2022
Presentation
COVID-19
NVX-CoV2373 Vaccine for COVID-19

World Vaccine Congress Webinar

Glenn, Gregory
Feb 21, 2022
Publication
The New England Journal of Medicine
COVID-19
Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
Keech, Cheryl, Glenn, Gregory M., Albert, Gary, et al.
Feb 18, 2022
Poster
RSV
In-depth Analytical Characterization and Structural Modeling of Novavax RSV F Nanoparticle Vaccine

11th International Respiratory Syncytial Virus Symposium

Maynard, Ernest
Jan 24, 2022
Publication
Novavax led
Vaccines
RSV
Clinical and economic outcomes associated with respiratory syncytial virus vaccination in older adults in the United States
Herring, William L., Zhang, Yuanhui, Shinde, Vivek, et al.
Dec 25, 2021
Publication
Novavax led
Pre-print
COVID-19
Immunogenicity and Safety Following a Homologous Boosater Dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): A Phase 2 Randomized Placebo-Controlled Trial
Mallory, Raburn, Formica, Neil, Pfeiffer, Susan, et al.